Literature DB >> 32965657

Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data.

Samuel Mon-Wei Yu1, Jeremy S Leventhal2, Paolo Cravedi3.   

Abstract

Entities:  

Keywords:  Autophagy; Diabetic kidney disease; Proximal tubule; Sodium glucose co-transporter 2; Tubuloglomerular feedback

Year:  2021        PMID: 32965657     DOI: 10.1007/s40620-020-00868-0

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


× No keyword cloud information.
  9 in total

Review 1.  Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

Authors:  Milton Packer
Journal:  J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 10.121

2.  SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition.

Authors:  Issei Tomita; Shinji Kume; Sho Sugahara; Norihisa Osawa; Kosuke Yamahara; Mako Yasuda-Yamahara; Naoko Takeda; Masami Chin-Kanasaki; Tatsuroh Kaneko; Eric Mayoux; Michael Mark; Motoko Yanagita; Hisakazu Ogita; Shin-Ichi Araki; Hiroshi Maegawa
Journal:  Cell Metab       Date:  2020-07-28       Impact factor: 27.287

3.  Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Authors:  Vlado Perkovic; Meg J Jardine; Bruce Neal; Severine Bompoint; Hiddo J L Heerspink; David M Charytan; Robert Edwards; Rajiv Agarwal; George Bakris; Scott Bull; Christopher P Cannon; George Capuano; Pei-Ling Chu; Dick de Zeeuw; Tom Greene; Adeera Levin; Carol Pollock; David C Wheeler; Yshai Yavin; Hong Zhang; Bernard Zinman; Gary Meininger; Barry M Brenner; Kenneth W Mahaffey
Journal:  N Engl J Med       Date:  2019-04-14       Impact factor: 91.245

Review 4.  Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.

Authors:  René Santer; Joaquim Calado
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 8.237

Review 5.  The tubular hypothesis of nephron filtration and diabetic kidney disease.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Nat Rev Nephrol       Date:  2020-03-09       Impact factor: 28.314

6.  SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy.

Authors:  Paola Cassis; Monica Locatelli; Domenico Cerullo; Daniela Corna; Simona Buelli; Cristina Zanchi; Sebastian Villa; Marina Morigi; Giuseppe Remuzzi; Ariela Benigni; Carlamaria Zoja
Journal:  JCI Insight       Date:  2018-08-09

7.  Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes.

Authors:  Kazuhiro Hasegawa; Shu Wakino; Petra Simic; Yusuke Sakamaki; Hitoshi Minakuchi; Keiko Fujimura; Kozi Hosoya; Motoaki Komatsu; Yuka Kaneko; Takeshi Kanda; Eiji Kubota; Hirobumi Tokuyama; Koichi Hayashi; Leonard Guarente; Hiroshi Itoh
Journal:  Nat Med       Date:  2013-10-20       Impact factor: 53.440

8.  The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.

Authors:  Erik J M van Bommel; Marcel H A Muskiet; Michaël J B van Baar; Lennart Tonneijck; Mark M Smits; Anna L Emanuel; Andrea Bozovic; A H Jan Danser; Frank Geurts; Ewout J Hoorn; Daan J Touw; Emil L Larsen; Henrik E Poulsen; Mark H H Kramer; Max Nieuwdorp; Jaap A Joles; Daniël H van Raalte
Journal:  Kidney Int       Date:  2019-10-10       Impact factor: 10.612

  9 in total
  3 in total

Review 1.  Cellular Senescence and Regulated Cell Death of Tubular Epithelial Cells in Diabetic Kidney Disease.

Authors:  Shuang Shen; Chuanyuan Ji; Kaifeng Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

2.  Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice.

Authors:  Vadim V Klimontov; Anton I Korbut; Iuliia S Taskaeva; Nataliya P Bgatova; Maksim V Dashkin; Nikolai B Orlov; Anna S Khotskina; Evgenii L Zavyalov; Thomas Klein
Journal:  World J Diabetes       Date:  2020-12-15

Review 3.  Role of the adaptive immune system in diabetic kidney disease.

Authors:  Lingyun Kong; Sofianos Andrikopoulos; Richard J MacIsaac; Laura K Mackay; David J Nikolic-Paterson; Niloufar Torkamani; Neda Zafari; Evelyn C S Marin; Elif I Ekinci
Journal:  J Diabetes Investig       Date:  2021-12-21       Impact factor: 4.232

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.